Skip to main content

Telehealth-ready AI-powered multi-parametric system for surveillance of COVID-19 and cardio-pulmonary chronic patients

Objective

The COVID-19 outbreak causes world health care systems to crumble under the load. This consortium proposes a Home-use/Point-of-Care device, incorporating improved clinical parameters, providing early detection, and monitoring of COVID-19 patients.
This consortium presents a computerized auscultation device – the PyXy – which provides expert-level lung and heart check-up. The PyXy brings breakthrough capabilities in terms of sound and infrasound analysis, body temperature, blood oxygen levels, heart rate and respiratory cycle, all analyzed by artificial intelligence (AI) for accurate diagnostic data. The device recently showed very promising results in relation to managing COVID-19 disease. Using H2020 funds, the consortium plans to introduce the PyXy to the market within 22 months: allowing anyone to perform diagnostic at an accuracy not normally accessible to the medical staff.
In this project the consortium will collect COVID-19 patient data and take the PyXy to high volume manufacturing level. The consortium gathers two technology provider SMEs – Sanolla, the developer of the PyXy device, and Medsensio, experts in AI for classification – together with an established player in the medical devices and e-health solutions – Riester. The work will be done in collaboration with four healthcare service providers (Natali, BeneVit, Helgeland and PhilonMed) to ensure the PyXy will be accepted by the market from all possible aspects.
We believe that PyXy is capable to substantially reduce the health-economic impact on healthcare and elderly care services by preventing hospitalization in emergent-care situations. In addition, as PyXy can be used by lesser skilled individuals, we believe it will potentially bridge the gap in care settings that face extreme shortage of skilled workers, and can even be used by informal caregivers at home reducing the overall hospitalization rate even further.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /natural sciences/computer and information sciences/artificial intelligence
  • /medical and health sciences/health sciences/health care services

Call for proposal

H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
See other projects for this call

Funding Scheme

IA - Innovation action

Coordinator

SANOLLA LTD
Address
19 Hamesila Street
3688519 Nesher
Israel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 1 777 212,50

Participants (6)

RUDOLF RIESTER GMBH
Germany
EU contribution
€ 968 187,50
Address
Bruckstrasse 31
72417 Jungingen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MEDSENSIO AS
Norway
EU contribution
€ 763 000
Address
Sykehusvegen 21
9019 Tromso
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
HELGELANDSSYKEHUSET HF
Norway
EU contribution
€ 416 875
Address
Sjoforsgata 36
8613 Mo I Rana
Activity type
Research Organisations
PHILONMED GMBH
Germany
EU contribution
€ 336 875
Address
Im Neuenheimer Feld 582
69120 Heidelberg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
BENEVIT HOLDING GMBH
Germany
EU contribution
€ 309 312,50
Address
Grasshoppersstrasse 21
72116 Mossingen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
NATALI (THE COMPANY FOR EMERGENCY MEDICAL SERVICES IN ISRAEL) LTD
Israel
EU contribution
€ 291 812,50
Address
4 Ha-khilazon St
5252268 Ramat Gan
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)